Recent Study Reveals Association Between Asymmetry of Drug-Induced Parkinsonism and Severity of Psychiatric Disease
Approximately one-third of patients with Huntington's disease (HD) experience depression. In 21 published case reports... MORE
- RT @amahajan001: “The moderate?outcome group showed cortical atrophy mainly in the sensorimotor and visuomotor areas and disturbed network… –@movedisorder
- Use our NEW Movement Disorders Specialist Directory to help you find important members of your care team.… https://t.co/4EpC356hGG –@movedisorder
- RT @movanfleni: The Fear of Falling Scale - Our last paper in @movedisorder reports the design and validation of a new instrument to assess… –@movedisorder
- Register now for Advanced Deep Brain Stimulation for Movement Disorders. Course Directors: Maria Fiorella Contarino… https://t.co/ifsIlWUoPK –@movedisorder
- #OpenAccess article in Movement Disorders: Cortical network fingerprints predict deep brain stimulation outcome in… https://t.co/8ZfvgiXmxL –@movedisorder
- Learn from past and present leaders of MDS in Leadership in Movement Disorders. This book is a key resource for mov… https://t.co/YRt8Xw1hdB –@movedisorder
- There’s possibility in stem cells but currently no stem cell treatments have been approved by regulatory agencies.… https://t.co/SAYc55Btgc –@MichaelJFoxOrg
- Health professionals who are attending #MDSCongress: join us at these events in Nice! https://t.co/P9A8hQrqrX https://t.co/giysOxBZBX –@movedisorder
- RT @KB_Schroeder: Looking forward to opportunities for #patientengagement in #research @ParkinsonDotOrg Research Centers. https://t.co/JMR… –@ParkinsonDotOrg
- This year for Shelley’s birthday, she fundraised on Facebook for her husband and father. “It is for these loved one… https://t.co/0xtmzCTmk4 –@ParkinsonDotOrg
- In the February 2019 episode of the MDS Podcast, Dr. Mered Parnes and Dr. Sara Schaefer discuss whether or not beni… https://t.co/PxPcMMY6Eu –@movedisorder
- Join #pingpongparkinson for the 1st @ittffoundation's World Parkinson's Table Tennis Championship on October 11-13.… https://t.co/deFldNUSi9 –@MichaelJFoxOrg
- What is the best way to distinguish normal pressure hydrocephalus (NPH) from microvascular ischemic disease?… https://t.co/MwzlCv7b7l –@movedisorder
- When #Parkinsons movement symptoms occur outside of Parkinson’s disease, they are called “parkinsonism.” Read our l… https://t.co/lQF61nST1G –@MichaelJFoxOrg
- Stay tuned! Early view articles of the MDS newsletter Moving Along will be posted here on the MDS Twitter account.… https://t.co/JDpIRzBhQX –@movedisorder
- RT @SJ_Schreiner: Clinicopathological heterogeneity in neurodegenerative diseases - Fascinating, as always, but probably particularly pres… –@movedisorder
- In this #podcast our Chief Scientific Officer @jbeck_PhD describes the goals of our PD GENEration initiative, how… https://t.co/dzUvTJlGQN –@ParkinsonDotOrg
- MDS Fundamentals Course: Restless Legs Syndrome. FREE for MDS Members and Non-Members. Faculty: Claudia Trenkwalder… https://t.co/7ztcu5Nu98 –@movedisorder
- RT @B_A_Benitez: Mendelian #Parkinson: genes & phenotypes #GCPD19 by Dr. Connie Marras from @ihpmeuoft explained differences & similarities… –@movedisorder
- RT @KB_Schroeder: .@ParkinsonDotOrg supports #patientengagement in #research through our Community Grants program. People with #Parkinsons… –@ParkinsonDotOrg
- In our latest #AskthePhD, scientists discuss how looking at genes and proteins can help us better measure, understa… https://t.co/VAHG9ULbVO –@MichaelJFoxOrg
- Jeff’s #KeyToPD is to #exercise with a buddy for support and accountability. Tag someone in the comments below to e… https://t.co/h1R5KYoSwv –@ParkinsonDotOrg
- The 2019 MDS International Congress is quickly approaching! Last chance to take advantage of discounted pre-registr… https://t.co/zSDOiyhm84 –@movedisorder
- RT @ColumbiaPS: With several targeted #ParkinsonsDisease drugs entering clinical trials, a new genetic testing and counseling program by @P… –@ParkinsonDotOrg
- RT @MDCP_Journal: Multiple system atrophy with predominant striato-nigral degeneration and TDP-43 pathology: an unusual variant of MSA. htt… –@movedisorder
- Get involved to help raise funds and awareness for the 10 million people worldwide living with #ParkinsonsDisease.… https://t.co/kMbzVtBvkZ –@ParkinsonDotOrg
- Your voice matters! Reach out to your members of Congress through our website and let them know how they can suppor… https://t.co/4f64TZlnBl –@MichaelJFoxOrg
- RT @terranovacorp: ?News Alert! @parkinsondotorg is hosting the Night at the Market this October at the @lincolneatery. Enjoy this culinary… –@ParkinsonDotOrg
- Recently, many people with #Parkinsons have been informed by their pharmacy that there is a shortage of #Sinemet or… https://t.co/0pFch8sqCP –@ParkinsonDotOrg
- "My father & I agreed to make this body of work for our family to understand his disintegration & to bring us close… https://t.co/rkmp1xce5y –@ParkinsonDotOrg
- Seeing their smiles is all the motivation we need to sign up for the @ToughMudder Classic/5K! Grab your #bestbuds a… https://t.co/Tmw7aD0qVl –@ParkinsonDotOrg
- Breanna and Mark are teaming up for this year’s Chicago Marathon for their family members who are living with PD! “… https://t.co/dMLdjBd5X4 –@ParkinsonDotOrg
- RT @uoftmedicine: What is disease modifying therapy when it comes to Parkinson’s? #UofTMed Prof Anthony Lang explains in @ParkinsonDotOrg’s… –@ParkinsonDotOrg
- Try these #eggcups for an easy, on-the-go #breakfast option. Simplify your #morning routine by keeping 'egg-stras'… https://t.co/di1b0zcfdX –@ParkinsonDotOrg
- #NationalRelaxationDay ?????????? https://t.co/9e0bfJmTqy –@ParkinsonDotOrg
- Public policy #advocacy is important to move #Parkinsons research forward. Learn more about our federal policy prio… https://t.co/uP87zHNWlG –@MichaelJFoxOrg
- Register for our upcoming Third Thursdays Webinar on August 15. Expert panelists will discuss the latest updates in… https://t.co/kG1vfxiVNS –@MichaelJFoxOrg
- In August, members of Congress are back home in their districts and states working for you. Our Parkinson’s Advocac… https://t.co/QbXVF3rFEf –@MichaelJFoxOrg
- Learn about how researchers are using stem cells to better understand and develop treatments for #Parkinsons in our… https://t.co/oIAzN3TjNB –@MichaelJFoxOrg
- “I have been a member of Team Fox for almost a decade. I have run marathons, flipped pancakes, and joined several f… https://t.co/WsSP65wnMV –@MichaelJFoxOrg
- Learn more about how MJFF is researching and investigating the role of PINK1 and parkin in #Parkinsons. https://t.co/SMJclexOCG –@MichaelJFoxOrg
- Technology is allowing more people to participate in research through online and smartphone studies. Read more on t… https://t.co/zxAFxpXXlZ –@MichaelJFoxOrg
- Read our latest #AsktheMD to learn more about the role of a social worker in #Parkinsons care. https://t.co/1pD3Ax8S26 –@MichaelJFoxOrg
- Thank you @AstroSerena and @Space_Station @ISS_CASIS for bringing science into space and supporting #Parkinsons re… https://t.co/lbUfET8a2v –@MichaelJFoxOrg
- The total cost of #Parkinsons is $52 billion every year. Your participation in Parkinson’s research and advocacy he… https://t.co/qH1Ft0QhhP –@MichaelJFoxOrg
ECT May Help Manage Depression In Patients With Huntington’s Disease
Approximately one-third of patients with Huntington's disease (HD) experience depression. In 21 published case reports where electroconvulsive therapy (ECT) was used to treat depression in patients with HD, 20 reported positive results from the therapy. No side effects were reported in these cases.
References:
-
Strassler D. Electroconvulsive Therapy May Benefit Patients With Huntington’s Disease. NeurologyAdvisor website. Published June 19, 2017. http://www.neurologyadvisor.com/movement-disorders/treating-psychiatric-symptoms-in-huntingtons-disease-electroconvulsive-therapy/article/669595/. Accessed July 16, 2017.
- Perrin JS, Merz S, Bennett DM, et al. Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder. Proc Natl Acad Sci U S A. 2012;109:5464-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325678/
-
Radke J. Is ECT a Good Treatment Option for Huntington’s Disease Patients? RareDiseaseReport website. Published June 20, 2017. http://www.raredr.com/news/ect-huntingtons. Accessed July 16, 2017.
Related Videos
Smartphone App to Help Parkinson’s Disease Patients Overcome Freezing of Gait
Approximately one-third of patients with Huntington's disease (HD) experience depression. In 21 published case reports... MORE
Researchers Say Parkinson’s Drug Needs Longer-Term "Home"
Approximately one-third of patients with Huntington's disease (HD) experience depression. In 21 published case reports... MORE
